Clinical, hormonal and molecular-genetic characteristics of monogenic diabetes mellitus associated with the mutations in the INS gene

Background: Currently more than 50 mutations of the INS gene are known to affect the various stages of insulin biosynthesis in the beta cells of the pancreas. However only individual cases of diabetes mellitus (DM) associated with heterozygous mutations in the coding region of the INS gene were reported in Russian Federation. We report a group of patients with a clinical manifestation of DM caused by mutations in both coding and non-coding regions of the INS gene. The patients with a mutation in the intron of the INS gene are reported for the first time in Russian Federation

Materials and methods: 60 patients with an isolated course of neonatal DM (NDM), 52 patients with a manifestation of DM at the age of 7–12 months and the absence of the main autoimmune markers of type 1 DM, 650 patients with the MODY phenotype were included in the study. NGS technology was used for molecular genetic research. Author’s panel of primers (Custom DNA Panel) was used for multiplex PCR and sequencing using Ion Ampliseq™ technology. The author’s panel “­Diabetes Mellitus” included 28 genes (13 candidate genes of MODY and other genes associated with DM).

Results: 13 heterozygous mutations were identified in 16 probands and 9 relatives. The majority of mutations were detected in patients with PNDM (18.75%) and in patients with an onset of DM at the age of 7–12 months (9.6%). Mutations in the INS gene were detected in 2 patients (0.3%) in the group with the MODY phenotype. Mutations in the INS gene were not detected in patients with transient NDM (TNDM). Analysis of clinical data in patients with PND and onset of diabetes at the age of 7–12 months did not show significant differences in the course of the disease. The clinical characteristics of the cases of MODY10 and diabetes caused by a mutation in the intron of the INS gene are reported in details.

Conclusion: The role of INS gene mutations in NDM, MODY, and DM with an onset at the age of 7–12 months was analyzed in a large group of patients. The clinical characteristics of DM due to a mutation in the intron of the INS gene are reported for the first time in the Russian Federation.

1. Gabbay KH, DeLuca K, Fisher JN, et al. Familial hyperproinsulinemia. An autosomal dominant defect. N. Engl. J. Med. 1976;294:911-915. doi: https://doi.org/10.1056/nejmi197604222941701

2. Barbetti F, Raben N, Kadowaki T, et al. Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic DNA amplified by polymerase chain reaction. J. Clin. Endocrinol. Metab. 1990;71(1):164-169. doi: https://doi.org/10.1210/jcem-71-1-164

3. Stoy J, Edghill EL, Flanagan SE, et al. Neonatal Diabetes International Collaborative Group. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc. Natl. Acad. Sci. U.S.A. 2007;104 (38):15040-15044. doi: https://doi.org/10/1073/pnas.0707291104

4. Colombo C, Porzio O, Liu M, Massa O, et al. Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (SIEDP). Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J. Clin. Invest. 2008;118(6):2148-2156. doi: https://doi.org/10.1172/jci33777

5. Edghill EL, Flanagan SE, Patch AM, et al. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes. 2008;57(4):1034-1042. doi: https://doi.org/10/2337/db07-1405

6. Molven A, Ringdal M, Nordbo AM, et al. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes. 2008;57(4):1131-1135. doi: https://doi.org/10/2337/db07-1467

7. Garin I, Edghill EL, Akerman I, et al. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci USA. 2010;107(7):3105-3110. doi: https://doi.org/10/1073/pnas.0910533107

8. Liu M, Haataja L, Wright J, et al. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLoS One. 2010;5(10):e13333. doi: https://doi.org/10.1371/journal.pone.0013333

9. Garin I, Perez de Nanclares G, Gastaldo E, et al. Permanent neonatal diabetes caused by creation of an ectopic splice site within the INS gene. PLoS One. 2012;7(1):e29205. doi: https://doi.org/10/1371/journal.pone.0029205

10. Liu M, Sun J, Cui J, et al. Insulin-gene mutations: from genetics and beta cell biology to clinical disease. Mol Aspects Med. 2015;42:3-18. doi: https://doi.org/10/1016/j.mam.2014.12.001

11. Panova A, Klementieva N, Goliusova D, et al. Generation of patient-specific iPSC disease model of neonatal diabetes with insulin mutation. FEBS Open Bio. 2019;9:22-002. doi: https://doi.org/10.1002/2211-5463.12675

12. Tikhonovich YV, Petryaikina EE, Rybkina IG, et al. Monogenic diabetes mellitus associated with a mutation in the insulin gene (INS). Problems of endocrinology. 2013;59(2):45-48. (In Russ.). doi: https://doi.org/10.14341/probl201359245-48

13. Tikhonovich YV, Zubkova NA, Tiulpakov AN. The personalized approach to neonatal diabetes therapy depending on the genetic defect. World Journal of Personalized Medicine. 2017;1(1):36-39 (In Russ.). doi: https://doi.org/10.14341/WJPM9304

14. Atanesyan RA, Uglova TA, Vdovina TM, et al. A clinical case of neonatal diabetes caused by INS gene mutation. Diabetes mellitus. 2019;22(2):170-176. (In Russ.). doi: https://doi.org/10.14341/DM9876

15. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. doi: https://doi.org/10.1038/gim.2015.30

16. Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285-291. doi: https://doi.org/10.1038/nature19057

17. Den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Hum Mutat. 2016;37(6):564-569. doi: https://doi.org/10.1002/humu.22981

18. Bell GI, Pictet RL, Rutter WJ et al. Sequence of the human insulin gene. Nature. 1980;284(5751):26-32. doi: https://doi.org/10.1038/284026a0

19. Raile K, O’Connell M, Galler A, et al. Diabetes caused by insulin gene (INS) deletion: clinical characteristics of homozygous and heterozygous individuals. Eur J Endocrinol. 2011;165(2):255-260. doi: https://doi.org/10.1530/EJE-11-0208

20. Wang J, Takeuchi T, Tanaka S, et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest. 1999;103(1):27-37. doi: https://doi.org/10.1172/JCI4431

21. Ron D. Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. J Clin Invest. 2002;109(4):443-445. doi: https://doi.org/10.1172/JCI15020

22. Kalmykovа ZA, Kononenko IV, Smirnova OM, Shestakova MV. Signaling pathways of β-cell death in type 2 diabetes mellitus: the role of innate immunity. Diabetes mellitus. 2020;23(2):174-184. (In Russ.). doi: https://doi.org/10.14341/DM10242

23. Moritani M, Yokota I, Tsubouchi K, et al. Japanese Study Group of insulin therapy for childhood and adolescent diabetes (JSGIT). Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age. Pediatr Diabetes. 2013;14(2):112-20. doi: https://doi.org/10.1111/j.1399-5448.2012.00917

24. Liu M, Wright J, Guo H, et al. Proinsulin entry and transit through the endoplasmic reticulum in pancreatic beta cells. Vitam Horm. 2014;95:35-62. doi: https://doi.org/10.1016/B978-0-12-800174-5.00002-8

25. Rapoport TA. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature. 2007;450(7170):663-669. doi: https://doi.org/10.1038/nature06384

26. Bonfanti R, Colombo C, Nocerino V, et al. Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies. Diabetes Care. 2009;32(1):123-5. doi: https://doi.org/10/2337/dc08-0783